AzTrials
AzTrials

Functional Abdominal Pain DisordersVICONCT06665867

VICO-trial: Video Consultations in the Follow-up of Children With Functional Abdominal Pain Disorders

A study testing Video consultation and Face-to-face consultation in people with Functional Abdominal Pain Disorders and Irritable Bowel Syndrome (IBS), run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) at 1 site in Netherlands.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this non-inferiority randomized controlled multi-center trial is to investigate the use of video consultations in the follow-up care of children aged 4 - 18 years old with functional abdominal pain disorders (FAPDs). Video consultations will be compared to face-to-face consultations. Read more about this study

Who is it for?
Ages 4 to 17 years
What is being tested?
Video consultation and Face-to-face consultation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
208 participants
Where
1 siteNetherlands
Study dates
1 Jun 2024to 30 Nov 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children aged 4 years to 17 years
  • Meeting the Rome IV criteria for one of the four types of Functional Abdominal Pain Disorders (FAPD's): functional dyspepsia, irritable bowel syndrome, abdominal migraine, functional abdominal pain - not otherwise specified.
  • Being able to conduct a video consultation

Who cannot join

  • If no follow-up consultation is indicated
  • If it is necessary that the follow-up consultations are face to face

Trial locations and contacts

1 site in 1 country.

M.M. Tabbers, Dr. Phd. contact

020 5668000

m.m.tabbers@amsterdamumc.nl

A. de Geus, Bsc. contact

020 5668000

Netherlands1 site, 1 recruiting
  • Amsterdam UMC, location AMC

    Amsterdam

    M.M. Tabbers, Dr. PhD., 020 5668000, m.m.tabbers@amsterdamumc.nl

    Recruiting

Other trials in Netherlands

About this study

The goal of this non-inferiority randomized controlled multi-center trial is to investigate the use of video consultations in the follow-up care of children aged 4 - 18 years old with functional abdominal pain disorders (FAPDs). Video consultations will be compared to face-to-face consultations. Clinical outcomes and patients' and parents' healthcare experience will be compared between both groups.

Primary outcome is adequate relief after 12 weeks: the hypothesis is that video consultations are not inferior to face-to-face consultations regarding clinical outcomes and that adequate relief will be the same for both groups.

Participants and/or parents will be asked to complete a diary for 1 week and a questionnaire after every consultation: at baseline, after 6 weeks and after 12 weeks.

Being tested
Video consultation, Face-to-face consultation
Keywords
E-health, Video consultations, Children, Functional abdominal pain disorders
Medical subject headings
Irritable Bowel Syndrome, Migraine Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Video consultationOther

    Participants will have their follow-up consultation with the physician via video. The consultation takes place via the participant's/parent's own device.

  • Face-to-face consultationOther

    The follow-up consultation with the physician will take place at the hospital.

Study groups in NCT06665867
Study groupRoleWhat they receive
Video consultationExperimentalThese participants are randomized for video consultations. Participants will receive two follow-up consultations via video.
Receives: Other: Video consultation
Face-to-face consultationActive comparatorThese participants are randomized for face-to-face consultations. Participants will receive two follow-up face-to-face consultations in the hospital.
Receives: Other: Face-to-face consultation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Adequate relief

    Proportion of participants reporting adequate relief. Adequate relief is a patient-reported outcome. Participants will be asked at 6 weeks and 12 weeks whether they have adequate relief of their Functional Abdominal Pain Disorder related complaints using a binary outcome (yes/no). Participants will complete a diary for a week and participants will be asked about adequate relief in the diary on day 7.

    Measured: After 12 weeks

Secondary outcomes (12)
  1. Pain intensity

    Number of children with a decrease of 30% of pain intensity after 12 weeks compared to baseline, measured on a Visual Analogue Scale (VAS) of 0-10. A score of 0 means no pain and a score of 10 means a lot of pain. The VAS-score is a mean score of 7 consecutive days. Children will be asked to fill in a diary for 7 days at baseline, after 6 weeks and after 12 weeks.

    Measured: 12 weeks

  2. Pain frequency

    Number of children with a decrease of 30% pain frequency per day after 12 weeks compared to baseline. Pain frequency will be recorded as number of hours of pain per day, as a mean of 7 consecutive days. Children will be asked to fill a diary for 7 days at baseline, after 6 weeks and after 12 weeks.

    Measured: 12 weeks

  3. Healthcare experience

    Both parents/guardians and children (if > 8 years old) will be asked to complete the Patient Reported Experience Measure for Specialist Medical Care questionnaire after every consultation. The questionnaire consists of 7 questions that participants can answer using a 10-point Likert scale, where a score of 1 means 'No, not at all' and a score of 10 means 'Yes, completely'. The questionnaire also contains one question with a binary answer (yes/no).

    Measured: 12 weeks

  4. Shared decision making (parents/guardians)

    Parents/guardians will be asked to complete the CollaboRATE questionnaire after every consultation. The questionnaire consists of three questions regarding shared decision making tasks during consultation. Responses to each question range from 0 ("no effort was made") to 9 ("every effort was made").

    Measured: 12 weeks

  5. Shared decision making (children)

    Children (if > 8 years old) will be asked to fill in the CollaboRATE questionnaire after every consultation. The questionnaire consists of three questions regarding shared decision making tasks during consultation. Responses to each question range from 0 ("no effort was made") to 9 ("every effort was made").

    Measured: 12 weeks

  6. Experience of patients and parents/guardians with video consultations

    Both parents/guardians and children (if > 8 years old) will be asked to fill in a questionnaire regarding their experience with the video consultation after every consultation.

    Measured: 12 weeks

  7. Experience of healthcare professionals with video consultations

    Upon completion of the inclusion phase of the trial (expected 1.5 years from its start), all participating physicians will complete a questionnaire about their experience with video consultations.

    Measured: End inclusion phase (expected 1.5 years)

  8. Number of no shows

    Proportion of no shows

    Measured: 12 weeks

  9. Number of extra face to face consultations

    Number of face to face consultations related to FAPD during the 12 week trial period, as extra to the two per protocol follow-up consultations. Participants will be asked a question in their questionnaire whether they went to the hospital (e.g. emergency department or extra consultation with their treating physician) for FAPD related complaints in the time between the two plannend consultations.

    Measured: 12 weeks

  10. Number of hours absent from school due to consultation

    Number of hours children were absent from school due to the consultation

    Measured: 12 weeks

  11. Number of hours absent from work due to consultation

    Number of work hours missed by parents/guardians due to the consultation

    Measured: 12 weeks

  12. Duration of consultations

    Duration of consultations for both face to face consultations and video consultations

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Oct 2024
  2. Study start1 Jun 2024
  3. Primary completion30 Nov 2025 (estimated)
  4. Study completion30 Nov 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
208 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06665867
Sponsor's protocol ID
2024.0101
Acronym
VICO
Status last verified
Oct 2024
First submitted
19 Jul 2024
Last updated
30 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Video consultation and Face-to-face consultation in people with Functional Abdominal Pain Disorders and Irritable Bowel Syndrome (IBS), run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 30 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact M.M. Tabbers, Dr. Phd. (020 5668000, m.m.tabbers@amsterdamumc.nl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Adequate relief (time frame: After 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in